Today’s Stock Market in 2-Minutes
August 14, 2026
August 14, 2026
August 14, 2026
August 14, 2026
August 13, 2026
Patrick Gruber, CEO of Gevo (NASDAQ: GEVO), shares how the company is pioneering renewable, drop-in hydrocarbon jet fuels that are cost-competitive with traditional petroleum-based alternatives. With over 450 patents and projects backed by a $1.63B DOE loan guarantee, Gevo is scaling commercial production through facilities in South Dakota and North Dakota. The company’s ethanol-based jet fuel, carbon capture, and RNG assets are unlocking significant revenue streams—positioning Gevo to become EBITDA positive in 2025. With $270M+ in cash, strategic partnerships, and bipartisan support for 45Z tax credits, Gevo is accelerating the transition to net-zero aviation fuels.
May 22, 2025Transaction Expands Star’s Business Services Platform, Enhances Revenue Diversity, and is Expected to Drive Significant Cost Synergies and Earnings Accretion Harte Hanks Stockholders to Receive $5.00 per Share, Consisting of Cash and Star Preferred Stock OLD GREENWICH, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (“Star”) (Nasdaq: STRR; STRRP), a diversified holding company, announced today that it has […]
August 14, 2026
Bitmine owns 4.8% of the total ETH coin supply of 120.7 million Bitmine is 96% of the way to the ‘Alchemy of 5%’ in just 14 months In July, ETH outperformed Nasdaq 100 by 2,500 basis points, the largest since July 2025, reflective of the strengthening fundamentals of crypto Bitmine repurchased 3.0 million common stock in the past week, and has repurchased over 19 […]
August 10, 2026
– Agreement positions B&W to deliver 20 50-megawatt steam turbines for customers on accelerated timelines – AI data centers and large-scale power generation projects driving energy demand (AKRON, Ohio – August 11, 2026) – Babcock & Wilcox (B&W) (NYSE: BW) announced today that it has signed an agreement with […]
August 11, 2026
– Perceptive Advisors provides approximately $7.0 million of additional investment to further support strategic growth initiatives including CGM+, Trinovium and the Company’s business transformation – – Trinity Biotech regains compliance with Nasdaq’s minimum bid price requirement – DUBLIN, Aug. 14, 2026 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused […]
August 14, 2026
August 14, 2026
August 14, 2026
August 14, 2026
August 14, 2026
August 14, 2026
August 14, 2026
August 14, 2026
August 14, 2026